课题基金 / 基金详情

Increase in chemo-and radiotherapy and cancer gene therapy by means of suppression of DNA repair genes

Increase in chemo-and radiotherapy and cancer gene therapy by means of suppression of DNA repair genes
通过抑制 DNA 修复基因来增加化疗、放疗以及癌症基因治疗
批准号:
14570540
负责人:
TAKIGUCHI Yuichi
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

TAKIGUCHI Yuichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Ku70 protein, cooperating with Ku80 and DNA-dependent protein kinase (DNA-PK) catalytic subunits (DNA-PKcs), is involved in DNA double-strand break (DNA DSB) repair and V(D)J recombination. Recent studies have revealed increased ionizing radiosensitivity in Ku70-deficient cells. The presented study, using a human squamous cell lung carcinoma cell line, demonstrated that introduction of an antisense Ku70 nucleic acid made the cells more radio-and chemosensitive than the parental cells. Ku70 protein expression was suppressed in the cells with antisense Ku70 construct when compared to the wild type cells : A relatively small but statistically significant increase in radiosensitivity of the cells was achieved by the introduction of the antisense Ku70. The increased radiosensitivity in vitro was accompanied by an approximately two-fold increase in a and alb values in a linear-quadratic model. The antisense Ku70 increased the chemosensitivity of the cells to some DNA-damaging agents such as bleomycin and methyl methanesulfonate, but not to cisplatin, mitomycin C, and paclitaxel. This system provides us with partial suppression of Ku70, and will be a useful experimental model for investigating the physiological roles of the DNA DSB repair gene.
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
Shingyoji M., Takiguchi Y.et al.: "Detection of tumor specific gene expression in bone marrow and peripheral blood from patients with small cell lung carcinoma."Cancer. 97・4. 1057-1062 (2003)
Shingyoji M.、Takiguchi Y. 等:“小细胞肺癌患者骨髓和外周血中肿瘤特异性基因表达的检测”。癌症 97・4 (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tada Y., JO.Wang, Wada A., Takiguchi Y.et al.: "Fas ligand-expressing tumors induce tumor-specific protective immunity in the inoculated hosts but vaccination with the apoptotic tumors suppresses antitumor immunity."Cancer Gene Therapy. 10・2. 134-140 (200
Tada Y.、JO.Wang、Wada A.、Takiguchi Y.等人:“表达 Fas 配体的肿瘤在接种的宿主中诱导肿瘤特异性保护性免疫,但接种凋亡肿瘤会抑制抗肿瘤免疫。”癌症基因治疗。 10・2.134-140(200)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tada Y., J O.Wang, Wada A., Takiguchi Y.et al.: "Fas ligand-expressing tumors induce tumor-specific protective immunity in the inoculated hosts but vaccination with the apoptotic tumors suppresses antitumor immunity."Cancer Gene Therapy. 10・2. 134-140 (20
Tada Y.、J O.Wang、Wada A.、Takiguchi Y.等人:“表达 Fas 配体的肿瘤在接种的宿主中诱导肿瘤特异性保护性免疫,但接种凋亡肿瘤会抑制抗肿瘤免疫。”癌症基因治疗10・2.134-140(20)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takiguchi Y.: "Hiccups as an adverse reaction to cancer chemotherapy."Journal of the National Cancer Institute. 94・10. 772-772 (2002)
Takiguchi Y.:“打嗝是癌症化疗的不良反应。”国立癌症研究所杂志 94・10 (2002)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
17
    A novel therapy for lung cancer targeting cancer stem cells.
    • 批准号:
      23591136
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      TAKIGUCHI Yuichi
    • 依托单位:
    Screening and validation of target molecules involved in mechanism of multi-modality therapy
    • 批准号:
      18590838
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.43万
    • 财政年份:
      2006
    • 负责人:
      TAKIGUCHI Yuichi
    • 依托单位:
    Positive interaction between tumor cells and tumor stromal cells for tumor growth.
    • 批准号:
      11670567
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      1999
    • 负责人:
      TAKIGUCHI Yuichi
    • 依托单位:
    国内基金
    海外基金
    生物钟基因BMAL1激活SirT3/Ku70/Bax通路调控线粒体功能在脓毒症心肌功能障碍中的作用
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      冷莹雪
    • 依托单位:
    脉冲电磁场通过成骨细胞初级纤毛钙信号级联介导Ku70激活特异性对抗放射骨损伤的机制研究
    类泛素化修饰靶向KU70蛋白在癌细胞有丝分裂中的作用机制研究
    • 批准号:
      2023JJ20032
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2023
    • 负责人:
      谢颖
    • 依托单位:
    核膜蛋白SUN2促进KAT6A乙酰化Ku70抑制肠癌DNA损伤修复和放疗抵抗分子机制研究
    • 批准号:
      --
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      33万元
    • 批准年份:
      2022
    • 负责人:
      刘丽娟
    • 依托单位: